HCA Healthcare (HCA)
(Delayed Data from NYSE)
$311.03 USD
-2.86 (-0.91%)
Updated Apr 17, 2024 04:00 PM ET
After-Market: $311.02 -0.01 (0.00%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth A Momentum A VGM
Income Statements
Fiscal Year end for HCA Healthcare, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 64,968 | 60,233 | 58,752 | 51,533 | 51,336 |
Cost Of Goods | 9,902 | 9,371 | 9,481 | 8,369 | 8,481 |
Gross Profit | 55,066 | 50,862 | 49,271 | 43,164 | 42,855 |
Selling & Adminstrative & Depr. & Amort Expenses | 45,417 | 41,764 | 39,480 | 35,848 | 35,594 |
Income After Depreciation & Amortization | 9,649 | 9,098 | 9,791 | 7,316 | 7,261 |
Non-Operating Income | -5 | 1,223 | 1,608 | -302 | -193 |
Interest Expense | 1,938 | 1,741 | 1,566 | 1,584 | 1,824 |
Pretax Income | 7,706 | 8,580 | 9,833 | 5,430 | 5,244 |
Income Taxes | 1,615 | 1,746 | 2,112 | 1,043 | 1,099 |
Minority Interest | 849 | 1,191 | 765 | 633 | 640 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 6,091 | 6,834 | 7,721 | 4,387 | 4,145 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 5,242 | 5,643 | 6,956 | 3,754 | 3,505 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 12,761 | 12,096 | 12,671 | 10,067 | 9,887 |
Depreciation & Amortization (Cash Flow) | 3,112 | 2,998 | 2,880 | 2,751 | 2,626 |
Income After Depreciation & Amortization | 9,649 | 9,098 | 9,791 | 7,316 | 7,261 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 276.41 | 294.67 | 328.75 | 343.61 | 348.23 |
Diluted EPS Before Non-Recurring Items | 19.01 | 16.89 | 17.50 | 11.61 | 10.50 |
Diluted Net EPS (GAAP) | 18.97 | 19.15 | 21.16 | 10.93 | 10.07 |
Fiscal Year end for HCA Healthcare, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 17,303.00 | 16,213.00 | 15,861.00 | 15,591.00 |
Cost Of Goods | NA | 2,584.00 | 2,417.00 | 2,478.00 | 2,423.00 |
Gross Profit | NA | 14,719.00 | 13,796.00 | 13,383.00 | 13,168.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 11,890.00 | 11,685.00 | 11,090.00 | 10,752.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 2,829.00 | 2,111.00 | 2,293.00 | 2,416.00 |
Non-Operating Income | NA | 7.00 | 2.00 | 1.00 | -15.00 |
Interest Expense | NA | 491.00 | 483.00 | 485.00 | 479.00 |
Pretax Income | NA | 2,345.00 | 1,630.00 | 1,809.00 | 1,922.00 |
Income Taxes | NA | 484.00 | 355.00 | 397.00 | 379.00 |
Minority Interest | NA | 254.00 | 196.00 | 219.00 | 180.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 1,861.00 | 1,275.00 | 1,412.00 | 1,543.00 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 1,607.00 | 1,079.00 | 1,193.00 | 1,363.00 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 271.19 | 275.42 | 278.20 | 280.96 |
Diluted EPS Before Non-Recurring Items | NA | 5.90 | 3.91 | 4.29 | 4.93 |
Diluted Net EPS (GAAP) | NA | 5.92 | 3.91 | 4.29 | 4.85 |